Dot blue letter attention, do not get lost~
The disclosure of the semi-annual reports of listed companies has gradually entered the peak period, and the invisible heavy stocks of fund managers have also been exposed.
CEIBS Fund Gülen holds a heavy position in OPCOM, a leading domestic orthokeratology company, and has increased its stake in the second quarter. The fund product Xingquan Herun managed by Xie Zhiyu appeared in the list of the top ten shareholders of five companies, Namewell, Yuanxing Energy, Puluo Pharmaceutical, Meihua Biological and Zhongwang Software, and Zhongwang Software was a newly opened stock.
Gülen increases the position of OPCOM Vision
On the evening of August 5, OPCOM released its semi-annual report, two fund products managed by Gülen appeared in the top ten circulating shareholders, CEIBS Medical Health increased its holdings in OPCOMvision in the second quarter, and CEIBS Medical Innovation directly bought the top ten circulating shareholders. Institutions such as Nord Value Advantage and Huabao CSI Medical have reduced their holdings in many OPCOM positions.
As of the end of the second quarter, CEIBS Health held 31.9189 million shares of OPCOM Vision, compared with the end of the first quarter, it increased its holdings by 6.5005 million shares, and the market value of the shares held at the end of the period reached 1.825 billion yuan, ranking the fourth largest circulating shareholder. CEIBS Medical Innovation directly became the company's tenth largest circulating shareholder, holding 3.5939 million shares at the end of the period, with a market value of 206 million yuan.
The top ten heavy stocks previously announced by CEIBS Medical Health are Aier Ophthalmology, WuXi AppTec, Kanglong Huacheng, Mindray Medical, Tigermed, Gloria Ying, Tablet Zai Zhen, Tongrentang, Tongce Medical, Kyushu Pharmaceutical, of which WuXi AppTec and Kyushu Pharmaceutical have disclosed semi-annual reports, and OPCOM does not appear in the top ten heavy stocks because its positions do not meet the disclosure standards.
OPCOM is regarded as a leading enterprise in china in orthokeratology, and is the first manufacturer in China to obtain both orthokeratology and rigid orthokeratometry product registration certificates.
The company's business development is directly related to the needs of myopia prevention and control. According to data from the National Health Commission, in 2020, the overall myopia rate of children and adolescents on the mainland was 52.7%, an increase of 2.5 percentage points over 2019 and a decrease of 0.9 percentage points from 2018; of which 14.3% were 6-year-old children, 35.6% were primary school students, 71.1% were junior high school students, and 80.5% were high school students.
Shanghai Securities Research believes that there are various ways to treat and correct myopia, among which the progress of orthokeratology lens intervention in myopia is remarkable, which has been clinically verified at home and abroad and recommended by the Guidelines for the Prevention and Treatment of Myopia by the National Health Commission. At present, the penetration rate of orthokeratology mirrors in mainland China is low, the market space is vast, and the industry scale is expected to be close to 25 billion yuan in 2025. At present, only 9 companies in mainland China have been registered by NMPA, and channels and services will be the key for manufacturers to increase their market share.
Xie Zhiyu heavy warehouse domestic CAD leader
Since the second quarter, the continuous adjustment of the stock price of the domestic CAD leader Zhongwang Software has attracted the attention of Xie Zhiyu, manager of Xingquan Fund, and Huang Xingliang, manager of Wanjia Fund.
On the evening of August 5, Zhongwang Software disclosed its semi-annual report, and the Xingquan Herun Hybrid Fund managed by Xie Zhiyu and the Wanjia Industry Preferred New Jin managed by Huang Xingliang became the top ten shareholders of the company. Among them, Xingquan Herun Hybrid Fund held 1.8837 million shares at the end of the period, with a market value of 394 million yuan, making it the seventh largest shareholder of the company. Wanjia Industry preferred 1.5 million shares at the end of the period, with a market value of 314 million yuan.
Up to now, the Xingquan Herun Fund managed by Xie Zhiyu has appeared in the list of the top ten shareholders of 5 companies, including Milkwell, Yuanxing Energy, Puluo Pharmaceutical, Meihua Biological and Zhongwang Software, of which Meihua Biology is the ninth largest heavy stock of the fund, and Milkwell, Yuanxing Energy, Puluo Pharmaceutical, and Zhongwang Software are all invisible heavy stocks.
During the second quarter, the market volatility increased, Xie Zhiyu instead bucked the trend and increased his position, Puluo Pharmaceutical, Meihua Biological, milkweed were all increased by him, Yuanxing Energy was reduced in some positions, and Zhongwang Software directly bought the top ten shareholders.
According to public information, Zhongwang Software is a leading domestic R & D and design industrial software supplier, mainly engaged in CAD/CAM/CAE and other R & D and design industrial software research and development, promotion and sales business.
According to IDC data, Zhongwang Software has a market share of 11.4% in China's manufacturing CAD software market in 2021, ranking fourth. The market share of Zhongwang Software has surpassed that of the overseas leader PTC, and it is very close to the third place AutoDesk (14%), and is the only domestic manufacturer to enter the "first camp", effectively breaking the monopoly situation of overseas leaders.
Huaxi Securities believes that compared with other domestic CAD manufacturers, in addition to the "magnitude" advantage of market share, Zhongwang Software has the advantage of "magnitude" in terms of users and cases, product research and development and iteration capabilities, sales and service systems, etc., and is in a "super" position, and the leading edge is prominent.
Lu Bin and other fund managers are clustered around the photovoltaic backplane leader
Jolywood disclosed its semi-annual report on the evening of August 4, and the company achieved operating income of 4.638 billion yuan in the first half of the year, an increase of 95.46% year-on-year; The net profit attributable to the mother was 231 million yuan, an increase of 642.89% year-on-year.
It is worth noting that in the list of the company's top ten shareholders, there are fund products of Lu Bin, Zheng Chengran, Li Qian and other star fund managers. GF High-end Manufacturing managed by Zheng Chengran reduced some of its upper-middle-level shares in the second quarter, while GF Xingcheng Mix and GF Chengxiang Mix were increasing their positions.
The Huatai Berry PV Industry Index Fund, managed by Li Qian, a fund manager of Huatai Berry, also increased its holdings of 1.2072 million shares in the second quarter. The Tianhong CSI Photovoltaic Industry Index Fund managed by Tianhong Fund Manager Liu Xiaoming has newly entered the company's top ten shareholders.
HSBC Jinxin Low Carbon Pioneer managed by Lu Bin became the company's top ten shareholders in the first quarter of this year, and its position remained unchanged in the second quarter, holding 7.4271 million shares at the end of the period, with a stock market value of 126 million yuan.
Jolywood mainly focuses on the research and development, production and sales of photovoltaic backplanes, N-type high-efficiency monocrystalline cells and modules, as well as the design, development, sales and operation and maintenance of photovoltaic application systems in the field of distributed household photovoltaics, and realizes the common development of the three major business sectors of photovoltaic backplanes, high-efficiency cells and modules, and photovoltaic application systems.
According to the semi-annual report, Jolywood's backplanes, high-efficiency modules and photovoltaic application systems accounted for 29.31%, 23.09% and 47.28% of the total revenue in the first half of the year, respectively.
The announcement pointed out that in the first half of the year, the domestic and foreign photovoltaic markets were hot, the demand for single glass modules was strong, and the demand for backplanes showed great growth. The company's main double-sided coated backplane products have been recognized by component customers worldwide, and its shipments increased by more than 140% over the same period last year.
Zhao Feng reduced his holdings in Huafeng Chemical
Huafeng Chemical recently disclosed its semi-annual report, and Zhao Feng's three-year holding of Ruiyuan Equilibrium Value appeared in the company's top ten shareholders list.
In the first quarter of this year, Ruiyuan Balanced Value held for three years to become the company's top ten shareholders, but in the second quarter, Zhao Feng reduced his holding of 6 million shares of Huafeng shares, and the remaining 35.2527 million shares were restricted shares, and the date of lifting the ban was September 29, 2022.
Zhao Feng's fund position is relatively balanced, including communication leader China Mobile, Internet leader Meituan, power battery leader Ningde era, Internet finance leader Oriental Wealth and so on.
In the second quarterly report, Zhao Feng said that the fund still mainly builds a portfolio from the bottom up method, and has higher requirements for the valuation, business model, competitive barriers and industry competition pattern of the target assets. The demand forecast of the industry is an important part of the research, but the accuracy of the demand forecast is not easy to grasp, and the overall valuation level of the industry will also reflect the prospects of the industry demand, so the fund chooses not to bet on the track and the industry, the industry distribution is relatively scattered, and the performance in the rebound process will be relatively moderate.
Looking forward to the future, Zhao Feng believes that China's economy will continue to pick up, but the speed of this recovery may be relatively moderate, when the market is too ahead, it is necessary to carefully adjust the risk, but the opportunity in the future is still greater than the risk, and the leading enterprises with lower valuations may still contribute to a relatively good return on investment.
Editor: Wang Zhaocheng
Copyright Notice
All original content of securities times platforms shall not be reproduced by any unit or individual without written authorization. Our company reserves the right to pursue the legal responsibility of relevant actors.
Reprint and cooperation can contact the Securities Times Assistant, WeChat ID: SecuritiesTimes
END
![Fund queen Gülen left office and lost 50 billion yuan in two and a half years[fig]](data:image/gif;base64,R0lGODlhAQABAIAAAP///wAAACwAAAAAAQABAAACAkQBADs=)